Today: 20 May 2026
Strategy (MSTR) drops after-hours as bitcoin stays weak and fresh share sales hang over the stock
31 December 2025
2 mins read

Strategy (MSTR) drops after-hours as bitcoin stays weak and fresh share sales hang over the stock

NEW YORK, December 31, 2025, 16:43 ET — After-hours

  • Strategy shares slid 2.3% in after-hours trading, hovering near the day’s lows.
  • A recent SEC filing showed the company sold stock and used the proceeds to buy more bitcoin.
  • Traders are watching bitcoin’s direction into 2026 and whether Strategy keeps tapping its share-sale program.

Strategy Inc shares fell 2.3% to $151.95 in after-hours trade on Wednesday, after swinging between $151.44 and $157.48 earlier in the day. Trading volume topped 15.6 million shares.

The move matters because Strategy has become one of the market’s most visible “bitcoin proxy” stocks — an equity that tends to move with the cryptocurrency — at a time when investors are recalibrating their risk appetite into year-end.

Bitcoin is on track for its first yearly loss since 2022, after struggling to recover from an October peak above $126,000, Reuters reported. “Bitcoin increasingly exhibits the characteristics of a risk asset … with a notable correlation to the U.S. equity market,” Linh Tran, a senior market analyst at XS.com, said in the report. Reuters

In a Dec. 29 filing, Strategy disclosed it sold 663,450 Class A shares for $108.8 million in net proceeds and used the money to buy 1,229 bitcoin at an average price of about $88,568 each. The company said it held 672,497 bitcoin as of Dec. 28, bought for $50.44 billion in total at an average price of $74,997, and had about $11.7 billion still available for issuance under its common-stock sales program.

That sales program is known as an at-the-market offering, or ATM — a mechanism that lets a company sell new shares into the market over time. For existing shareholders, repeated issuance can be dilutive, meaning it spreads ownership across a larger share count.

At bitcoin’s recent levels, Strategy’s disclosed holdings are worth roughly $59 billion, leaving the stock highly sensitive to day-to-day moves in the token as well as shifts in investor tolerance for leverage and dilution.

The feedback loop cuts both ways. When bitcoin rises, Strategy’s ability to raise fresh equity can expand; when the token weakens, the market can push back on additional share sales, tightening the company’s room to maneuver.

Strategy describes itself as a “Bitcoin Treasury Company,” a label for firms that hold bitcoin as a core balance-sheet asset rather than a side investment. Strategy

That positioning has pulled the stock closer to crypto market plumbing than to the software business that originally defined MicroStrategy, the name Strategy used before its rebrand.

Traders also flag round-number levels after Wednesday’s slide. The $150 area is in focus after the stock probed just above it, while the mid-$150s mark the zone the shares struggled to hold into the close.

Next up, investors will watch for the company’s next disclosures around bitcoin purchases and equity issuance, along with any follow-through in the token as markets turn the calendar to 2026.

Strategy is estimated to report earnings on Feb. 4, according to Nasdaq.

For now, the stock’s after-hours drop underscored the same dynamic that has defined recent months: Strategy trades less like a conventional software name and more like a levered bet on bitcoin’s next move.

Stock Market Today

  • Experian Shares Fall Despite Record Results and $1 Billion Buyback
    May 20, 2026, 4:55 AM EDT. Experian PLC shares fell 4.1% to 2,596p despite reporting record annual results and announcing a $1 billion share buyback program. For the year ending March, revenue rose 13% to $8.43 billion, with earnings before interest and tax up 15% at $2.41 billion. The company raised its full-year dividend by 11% to 69.25 cents per share. CEO Brian Cassin described the year as a record one and guided 6-8% organic sales growth for the next year, below the City consensus of 8%, citing Middle East uncertainties. Analysts noted the share price drop reflects fears of AI disruption despite strong earnings growth forecasts.

Latest articles

Klaviyo Stock Is Near Its Low — The Next Move Hinges On One Big Question

Klaviyo Stock Is Near Its Low — The Next Move Hinges On One Big Question

20 May 2026
Klaviyo closed Tuesday at $14.70, up 0.6%, but remained near its 52-week low after a sharp post-earnings drop. A May 18 Form 144 notice signaled potential insider sales. Shares were down about 27% in the past month and 57% over the year, with a market value near $4.4 billion. First-quarter revenue rose 28% to $358 million, but growth is forecast to slow.
Chewy Shares Slide on CEO Talk of “Stretched Consumer”

Chewy Shares Slide on CEO Talk of “Stretched Consumer”

20 May 2026
Chewy Inc. shares dropped 9.1% to $19.66 Tuesday after CEO Sumit Singh warned U.S. consumers are more financially strained than earlier this year. The decline put Chewy near its 52-week low ahead of its June 10 earnings report. Singh made the comments at a J.P. Morgan conference, citing multiple data points on weaker consumer demand. Petco fell 2.9%, while BARK rose 7.5% and Amazon slipped 2.1%.
Meiwu Technology Stock Jumps Again After 97% Surge: Why WNW Is Moving Now

Meiwu Technology Stock Jumps Again After 97% Surge: Why WNW Is Moving Now

20 May 2026
Meiwu Technology shares jumped 97% to $4.75 Tuesday and rose another 12% premarket after the company raised $15.65 million in a private share sale to fund an AI skincare platform. The rally follows a 1-for-100 reverse share split in April and earlier $14 million direct offering. Meiwu warned its new platform is early-stage and faces regulatory risks.
AI stocks today: Nvidia, AMD tick higher as year-end trade turns cautious
Previous Story

AI stocks today: Nvidia, AMD tick higher as year-end trade turns cautious

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD
Next Story

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD

Go toTop